Morgan Stanley strategists, led by Mike Wilson, maintain a positive outlook on the U.S. stock market despite recent tensions in Iran and the Middle East. According to Jin10, the team believes that unless there is a significant and sustained surge in oil prices, these geopolitical conflicts are unlikely to alter their bullish stance. They reference the historical performance of the S&P 500 index following geopolitical risk events, noting that such events have not typically resulted in prolonged market volatility.
The strategists argue that the primary bearish factor would be a substantial and lasting increase in oil prices, which could negatively impact what they perceive as a strengthening business cycle. They state, "Unless oil prices surge in a historically significant manner and remain high, recent events are unlikely to change our bullish view on U.S. stocks over the next 6 to 12 months."
For Wilson, the healthcare sector remains the preferred defensive choice due to its attractive valuations, improving earnings, and diminishing policy uncertainties, which are likely to draw broader investor interest.